Hyderabad Paediatrician Sivaranjani Santosh Resigns From IAP, Alleges Pharmaceutical Influence

Hyderabad-based paediatrician Dr. Sivaranjani Santosh has publicly resigned from the Indian Academy of Pediatrics (IAP), leveling serious allegations of pharmaceutical influence and ethical compromise against the organization’s leadership. In a public post on the social media platform X, Dr. Santosh stated that the acceptance of her resignation has freed her from professional restraints, allowing her to openly criticize the academy’s practices. Her primary grievance centers around the promotion and medical endorsement of ORSL, an apple-flavored electrolyte drink that is distinct from standard WHO-approved oral rehydration solutions.

The controversy stems from the marketing of ORSL, which critics argue is often mistakenly prescribed or purchased as a standard ORS replacement for pediatric dehydration. Medical professionals have long cautioned that using non-standard sugary beverages during acute diarrhea can exacerbate dehydration in young children. Dr. Santosh has called for a formal investigation into how such commercial products receive promotional space and implicit endorsement within prestigious medical bodies. She alleges that financial relationships between major pharmaceutical manufacturers and healthcare associations undermine clinical guidelines and compromise patient safety.

This public fallout has reignited a critical debate surrounding corporate sponsorships and ethical standards within Indian medical associations. Activists and pediatricians are demanding greater transparency regarding the financial contributions made by pharmaceutical companies to clinical organizations. The IAP has yet to issue an official response to the allegations, but the issue is expected to prompt internal reviews on conflict-of-interest policies. Observers note that this controversy could lead to stricter regulations governing product endorsements by medical professionals and associations across India.